Treating type 2 diabetes. Difference needs to be explained

Comment

E H Christiansen. BMJ. 1999.

. 1999 Mar 6;318(7184):667; author reply 668.

No abstract available

Comment on

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.
UK Prospective Diabetes Study Group. UK Prospective Diabetes Study Group. BMJ. 1998 Sep 12;317(7160):703-13. BMJ. 1998. PMID: 9732337 Free PMC article. Clinical Trial.
Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group.
UK Prospective Diabetes Study Group. UK Prospective Diabetes Study Group. BMJ. 1998 Sep 12;317(7160):713-20. BMJ. 1998. PMID: 9732338 Free PMC article. Clinical Trial.